Riskpilot← Back to searchSign inGet full accessShire Sweden AB
ABDissolvedOrg 5568189210Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201091 employees
Revenue 2020
SEK 1,8B
+45% vs 2018
EBITDA margin
1.9%
+21% vs 2018
Equity ratio
18.3%
Financial strength
Net profit 2020
SEK 12,5M
-44% vs 2018
| Revenue | SEK 1,8B | +45% |
| EBITDA | SEK 34,7M | +21% |
| Net profit | SEK 12,5M | -44% |
| Total assets | SEK 584M | -11% |
| Equity | SEK 107M | +13% |
| Employees | 91 | — |
Legal name
Shire Sweden AB
Org number
5568189210
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14 september 2010
Share capital
SEK 0
Employees
91 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-03-31
Financial year
January – December
Company purpose
Föremålet för bolagets verksamhet skall vara att vara aktivt inom alla områden inom läkemedelsindustrin, innefattande forskning, utveckling, framställning, testning, marknadsföring och försäljning av läkemedel samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2020 |
|---|---|---|---|---|
| Revenue | 466 446 | 823 908 | 1 271 667 | 1 846 116 |
| Staff expenses | — | — | — | — |
| EBITDA | 10 804 | 35 408 | 28 551 | 34 685 |
| Depreciation & amort. | −3 642 | −5 781 | −6 624 | −6 813 |
| EBIT | 7 162 | 29 627 | 21 927 | 27 872 |
| Net financials | 3 151 | −4 195 | 9 059 | −9 346 |
| Profit before tax | 10 313 | 25 432 | 30 986 | 18 526 |
| Tax | −2 377 | −6 779 | −8 611 | −5 997 |
| Net profit | 7 936 | 18 653 | 22 375 | 12 529 |
| Item | 2016 | 2017 | 2018 | 2020 |
|---|---|---|---|---|
| Total assets | 292 456 | 520 633 | 657 746 | 584 009 |
| Equity | 20 211 | 72 063 | 94 439 | 106 968 |
| Long-term debt | 0 | 0 | 0 | 5 134 |
| Short-term debt | 272 245 | 448 571 | 562 817 | 471 907 |
| Total debt | 272 245 | 448 571 | 562 817 | 477 041 |
EBITDA margin
1.9%
This company
15.8%
Market median
-88% vs market
20162020
Equity ratio
18.3%
This company
38.2%
Market median
-52% vs market
20162020
Return on equity
11.7%
This company
18.4%
Market median
+36% vs market
20162020
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20162020
Asset turnover
3.16×
This company
1.12×
Market median
+182% vs market
20162020
Debt / equity
4.46×
This company
0.62×
Market median
-619% vs market
20162020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-01-01 – 2020-03-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
RH Chief Auditor | Chief Auditor | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Chairman | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Shire Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Resul Hamurcu | Chief Auditor | 0 companies |
| Jacob Fredrik Westin | Board of Directors | 0 companies |
| Sofia Therese Hultman | Board of Directors | 0 companies |
| Vatroslav Mateljic | Chairman | 0 companies |